Abstract
Testing for anti-hepatitis C virus (HCV) antibodies in pools may reduce blood screening costs, making this approach affordable for developing countries, provided that the dilution of infected blood does not significantly increase the number of undetectable viral particles, especially in seroconverters. This study assessed the delay in detection of HCV antibodies in five HCV seroconversion panels, tested in pools of 6-48 samples, and estimated the risk of transfusion-transmitted HCV caused by pooling. The delay in detection of positive samples was 5-12 days for pools of all sizes, adding 7% to the risk of HCV transmission that occurs when blood donors' samples are tested individually. © 2007 The Authors; Journal compilation © 2007 Blackwell Publishing Ltd.
Author supplied keywords
Cite
CITATION STYLE
Sarov, B., Novack, L., Galai, N., Yaari, A., Orgel, M., Safi, J., … Shinar, E. (2007). Estimation of delay in detecting hepatitis C virus antibodies in pools compared to individual testing on seroconversion panels. Clinical Microbiology and Infection, 13(7), 737–739. https://doi.org/10.1111/j.1469-0691.2007.01740.x
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.